Advertisement
YOU ARE HERE: LAT HomeCollectionsFda
IN THE NEWS

Fda

BUSINESS
February 12, 2014 | By Ricardo Lopez
The U.S. Food and Drug Administration is investigating the illnesses of children in three states in recent months that have been linked to Uncle Ben's infused rice served in schools. The cluster of illnesses have affected children in Texas, Illinois and North Dakota. At three schools in Katy, Texas, 34 students and four teachers experienced skin reactions, burning, headaches and nausea last week after eating Uncle Ben's "Mexican flavor" infused rice.  The symptoms lasted about 90 minutes, officials said.  Similar reactions were reported at an Illinois school in December and a daycare center in North Dakota in October.  Mars Foodservices, which produces the product, has recalled 5- and 25-pound bags of various rice products primarily sold to schools, restaurants, hospitals and other commercial establishments.
Advertisement
NEWS
June 14, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
FDA to Kellogg: One of your facilities is contaminated with listeria. Clean it up.  That’s the gist of a warning letter, dated June 7, the Food and Drug Administration sent to Kellogg after a February inspection of a cookie plant found Listeria monocytogenes , the bacteria that causes the food poisoning listeriosis . The Augusta, Ga. plant makes various Keebler and Famous Amos cookies. The agency didn’t find the pathogen in any Kellogg foods, but on and around conveyor belts in the production line.
NEWS
August 2, 2011 | By Andrew Seidman
A coalition of nearly 30 organizations in the animal agriculture industry sent a letter to the heads of the House and Senate on Tuesday, asking lawmakers not to intervene as the Food and Drug Administration considers whether to approve genetically engineered salmon as food. The letter comes more than a month after the House approved an amendment, by voice acclamation, to an appropriations bill that would strip the FDA of funding to study the salmon. On July 15, members of the House and Senate sent letters to the FDA asking it to abandon its consideration of modified salmon as food, and threatened to propose legislation to bar further study of the fish if the agency does not comply.
BUSINESS
February 2, 2012 | By Matt Stevens
Trace levels of the fungicide carbendazim were discovered in domestic orange juice samples, the Food and Drug Administration reported Thursday. But the FDA said the levels pose no safety risk, and the orange juice will not be recalled. FDA spokeswoman Siobhan DeLancey said that most of the samples taken were from concentrated products that will be blended down into the orange juice consumers drink, so the low levels of carbendazim will almost disappear. “We didn't have any evidence to indicate that the product on the market was any safety problem at all,” DeLancey said.
NEWS
September 14, 2010
The Food and Drug Administration released information Tuesday suggesting it's unimpressed by a weight-loss medication under development by Arena Pharmaceuticals Inc. and casting doubt on the drug's eventual approval. An FDA advisory committee is scheduled to meet Thursday and vote on whether to recommend approval of the drug, lorcaserin. But in documents released Tuesday in advance of the meeting, the FDA noted that studies on lorcaserin showed the average weight loss while taking the drug was not significantly different than the average weight loss among people taking a placebo.
BUSINESS
October 30, 2013 | By David Pierson
About 12% of spices imported into the U.S. each year is contaminated with insects, animal excrement, rodent hair and even rubber bands, according to a Food and Drug Administration draft report released Wednesday. The study was conducted in response to recent cases of salmonella found in imported spices. It looked at ways to reduce the rates of human illness caused by contamination in the seasonings. “Nearly all of the insects found in spice samples were stored product pests, indicating inadequate packing or storage conditions.
SCIENCE
June 18, 2013 | By Melissa Healy
The Food and Drug Administration says it is investigating the unexplained deaths of two patients in the wake of receiving intramuscular injections of the antipsychotic medication Zyprexa (generic name olanzapine). The patients died three to four days after receiving appropriate doses of Zyprexa Relprevv, which is designed to release slowly into the blood over two to four weeks and provide regular dosing for adults with schizophrenia. The FDA says the deaths occurred well after the three-to-four-hour window following injection during which patients should be monitored in a physician's office for a potentially deadly complication called post-injection delirium sedation syndrome (PDSS)
NEWS
December 27, 2010 | By Mary Forgione, For the Los Angeles Times
Remoxy may not have the name recognition of Percocet, but its makers say it has something Percocet and similar drugs don't have -- little potential for addiction. They've asked, again, that the FDA approve Remoxy. Like Percocet, Remoxy contains oxycodone, an opiate that Americans like quite a bit. Unlike other formulations, however, Remoxy employs a special controlled-release formula designed to limit its abuse. The National Institute on Drug Abuse reports that of 7 million Americans abusing prescription drugs in 2009, 5.3 million were abusing pain relievers.
NEWS
December 3, 2010 | By Mary Forgione, For the Los Angeles Times
Invisible braces sound perfect, especially if you're an adult trying to look and act your age. But the FDA says Invisalign, which makes one type of invisible braces, failed to report information on side-effects in patients. Here's the Associated Press story detailing some patients' complaints about allergic reactions to the devices  and the FDA advisory letter . And, of course, the response from Invisalign maker Align Technology Inc. in San Jose. None of this is to say that crooked teeth should stay crooked.
NEWS
June 21, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
The Food and Drug Administration says it could use an international helping hand in testing the influx of imported drugs and food.  Acknowledging the monitoring difficulties inherent in a global economy, the agency said in an announcement Monday that it needs to transform the way it protects the nation's food and drug supply, teaming up with other agencies around the world to ensure quality and safety of the products it regulates. “Global production of FDA-regulated goods has exploded over the past ten years.  In addition to an increase in imported finished products, manufacturers increasingly use imported materials and ingredients in their U.S. production facilities, making the distinction between domestic and imported products obsolete,” Commissioner of Food and Drugs Margaret A. Hamburg said in the announcement.
Los Angeles Times Articles
|